Assay Detail
Functional
CHEMBL5502633
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiproliferative activity against human DLD-1 cells harboring STAT3 over activation assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | DLD-1 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 2 | 6.93 | 7.82 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5558267 | — | — | 1 | 7.82 |
| CHEMBL64130 | NAPABUCASIN | 3.0 | 1 | 6.03 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5558267 | — | IC50 | = | 15.02 | nM | 7.82 |
| CHEMBL64130 | NAPABUCASIN | IC50 | = | 944.0 | nM | 6.03 |